Investors

Date	Name	Title	Type	Shares Traded	Price Range
Oct 5, 2010	goldstein joseph l	Director	Automatic Sell	3,152	28.40
Nov 14, 2012	goldberg murray a	Officer	Automatic Sell	3,156	147.65 - 149.18
Oct 6, 2010	brown michael s	Director	Automatic Sell	3,235	29.05
Feb 14, 2012	gilman alfred g	Director	Disposition (Non Open Market)	3,266	111.01
Mar 31, 2011	brown michael s	Director	Automatic Sell	3,309	44.65
Feb 3, 2010	roberts william	Officer	Automatic Sell	3,315	27.66 - 28.08
Dec 11, 2012	aberman michael s	Officer	Automatic Sell	3,368	184.85 - 185.18
Sep 7, 2011	aberman michael s	Officer	Automatic Sell	3,377	67.39 - 70.39
Dec 17, 2012	goldberg murray a	Officer	Disposition (Non Open Market)	3,400	n/a
Mar 9, 2011	goldstein joseph l	Director	Automatic Sell	3,495	39.35
Aug 24, 2012	roberts william	Officer	Automatic Sell	3,500	n/a
Sep 1, 2011	vagelos p roy	Officer	Automatic Sell	3,500	60.00
Mar 7, 2013	schleifer leonard s	Officer	Automatic Sell	3,534	175.13
Dec 7, 2011	roberts william	Officer	Disposition (Non Open Market)	3,647	n/a
Mar 19, 2013	schleifer leonard s	Officer	Automatic Sell	3,655	175.02
May 1, 2013	mccorkle douglas s	Officer	Automatic Sell	3,662	233.53
Jan 12, 2012	vagelos p roy	Officer	Disposition (Non Open Market)	3,786	n/a
Jun 30, 2011	vagelos p roy	Officer	Disposition (Non Open Market)	3,798	n/a
Nov 30, 2012	aberman michael s	Officer	Automatic Sell	3,904	180.08 - 184.00
Jul 12, 2011	roberts william	Officer	Automatic Sell	3,939	56.67 - 57.55
Showing 81-100 of 627 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.